In Silico and Ex silico ADME approaches for drug discovery.
about
New antimalarial hits from Dacryodes edulis (Burseraceae)--part I: isolation, in vitro activity, in silico "drug-likeness" and pharmacokinetic profilesThe potential of anti-malarial compounds derived from African medicinal plants, part III: an in silico evaluation of drug metabolism and pharmacokinetics profiling.An in silico evaluation of the ADMET profile of the StreptomeDB database.In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin.Antiparasitic Sesquiterpenes from the Cameroonian Spice Scleria striatinux and Preliminary In Vitro and In Silico DMPK Assessment.Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitorsCombining 2D and 3D in silico methods for rapid selection of potential PDE5 inhibitors from multimillion compounds' repositories: biological evaluation.Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.Discovery of Potent ALK Inhibitors Using Pharmacophore-Informatics Strategy.Molecular Docking Analysis of Selected Clinacanthus nutans Constituents as Xanthine Oxidase, Nitric Oxide Synthase, Human Neutrophil Elastase, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9 and Squalene Synthase InhibitorsPharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design.Advances in antiviral drug discovery and development: Part II: Advancements in antiviral drug developmentHow “drug-like” are naturally occurring anti-cancer compounds?Assessing the pharmacokinetic profile of the CamMedNP natural products database: an in silico approach
P2860
Q28535324-4962B9A9-CA5F-4CE6-936E-56B85D2A4AD5Q30315979-7FAADBC8-17CE-4C8D-B560-31614BD33512Q30317740-930BD37E-89E8-4498-AA1B-797E96130EA7Q30317914-DEA398B1-92EE-4DCD-9384-0177FC18DC8CQ33825850-B0F3F188-F079-49C5-97E7-A5CF986764D0Q33922695-5335A635-7332-4CB5-98FF-F6BE4DEFC6CBQ34030603-5AF9A71B-DB0B-4601-BD6F-B21C56D7885DQ36909306-3C0D6E40-A57E-44ED-8279-9E82A9092514Q37835282-785C464E-9B75-4014-A406-894E3074CDB0Q38687108-E8C2B718-CA9E-4AF5-BB3F-211C277CB297Q39005095-6244BF9C-6123-41BA-992E-FC09F760DAA0Q53792938-E2CE3DBC-B8FC-498D-B79D-EA4FD745006CQ56749631-24BF8ECC-F200-4930-AE9F-90CF34767A17Q58860057-926EEDFC-E4EB-41EC-BB41-E23580EDA7BCQ58862110-FF0B987A-F951-418D-B937-26D05FBC3F22
P2860
In Silico and Ex silico ADME approaches for drug discovery.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
In Silico and Ex silico ADME approaches for drug discovery.
@ast
In Silico and Ex silico ADME approaches for drug discovery.
@en
type
label
In Silico and Ex silico ADME approaches for drug discovery.
@ast
In Silico and Ex silico ADME approaches for drug discovery.
@en
prefLabel
In Silico and Ex silico ADME approaches for drug discovery.
@ast
In Silico and Ex silico ADME approaches for drug discovery.
@en
P2093
P356
P1476
In Silico and Ex silico ADME approaches for drug discovery.
@en
P2093
Aacytelkos Papp
Ferenc Darvas
György Dormán
György Keseru
László Urge
Péter Krajcsi
P304
P356
10.2174/1568026023392841
P577
2002-12-01T00:00:00Z